Delivery Order SPE2DB22D2007-SPE2DB25FJ4VZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Armodafinil 250 mg tablets in 30-count units. This firm fixed-price delivery order, valued at $1,984.17, represents a non-competitive set-aside award and is scheduled for completion by August 20, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $1,196.97. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Armodafinil 250mg (30-count packages) with a ceiling value of $1,696.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Armodafinil 250 mg tablets (30-count units) with a contract ceiling value of $5,490.42. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.35 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,345.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,672.50. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and involves no set-aside designation. Performance will be conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $2,863.95, was competitively awarded without set-aside designation and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4VZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $2,191.50. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025. The award was made through open competition with no set-aside designation, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The delivery order falls under the company's comprehensive pharmaceutical supply agreement with the DLA, which enables the provision of a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. This particular order for Armodafinil, a wakefulness-promoting agent, reflects AmerisourceBergen's role in supplying specialty pharmaceuticals to meet the medical needs of the Department of Defense and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/11/25 |